These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Innovative monotherapy trial designs for the assessment of antiepileptic drugs: a critical appraisal. Perucca E Eur J Clin Pharmacol; 1998 Mar; 54(1):1-5. PubMed ID: 9591922 [TBL] [Abstract][Full Text] [Related]
6. Efficacy, safety, and tolerability of lacosamide monotherapy versus controlled-release carbamazepine in patients with newly diagnosed epilepsy: a phase 3, randomised, double-blind, non-inferiority trial. Baulac M; Rosenow F; Toledo M; Terada K; Li T; De Backer M; Werhahn KJ; Brock M Lancet Neurol; 2017 Jan; 16(1):43-54. PubMed ID: 27889312 [TBL] [Abstract][Full Text] [Related]
7. Monotherapy trials with the new antiepileptic drugs: study designs, practical relevance and ethical implications. Perucca E; Tomson T Epilepsy Res; 1999 Feb; 33(2-3):247-62. PubMed ID: 10094435 [TBL] [Abstract][Full Text] [Related]
8. When clinical trials make history: demonstrating efficacy of new antiepileptic drugs as monotherapy. Perucca E Epilepsia; 2010 Oct; 51(10):1933-5. PubMed ID: 20491875 [TBL] [Abstract][Full Text] [Related]
9. Designing clinical trials to assess antiepileptic drugs as monotherapy : difficulties and solutions. Perucca E CNS Drugs; 2008; 22(11):917-38. PubMed ID: 18840033 [TBL] [Abstract][Full Text] [Related]
10. Innovative designs of controlled clinical trials in epilepsy. Gram L; Schmidt D Epilepsia; 1993; 34 Suppl 7():S1-6. PubMed ID: 8243373 [TBL] [Abstract][Full Text] [Related]
11. Oxcarbazepine versus phenytoin monotherapy for epilepsy. Muller M; Marson AG; Williamson PR Cochrane Database Syst Rev; 2006 Apr; (2):CD003615. PubMed ID: 16625587 [TBL] [Abstract][Full Text] [Related]
12. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsy. de Silva M; MacArdle B; McGowan M; Hughes E; Stewart J; Neville BG; Johnson AL; Reynolds EH Lancet; 1996 Mar; 347(9003):709-13. PubMed ID: 8601999 [TBL] [Abstract][Full Text] [Related]
14. Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy. Powell G; Saunders M; Marson AG Cochrane Database Syst Rev; 2010 Jan; (1):CD007124. PubMed ID: 20091617 [TBL] [Abstract][Full Text] [Related]
16. Study protocol for a pragmatic randomised controlled trial comparing the effectiveness and cost-effectiveness of levetiracetam and zonisamide versus standard treatments for epilepsy: a comparison of standard and new antiepileptic drugs (SANAD-II). Balabanova S; Taylor C; Sills G; Burnside G; Plumpton C; Smith PEM; Appleton R; Leach JP; Johnson M; Baker G; Pirmohamed M; Hughes DA; Williamson PR; Tudur-Smith C; Marson AG BMJ Open; 2020 Aug; 10(8):e040635. PubMed ID: 32847927 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy. Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191 [TBL] [Abstract][Full Text] [Related]